Roche again extends $4.3 blillion offer for Spark amid FTC review

Roche on Friday announced another extension of the Swiss drugmaker's $4.3 billion offer for gene therapy specialist Spark Therapeutics, this time until June 3, saying a review by U.S. authorities is taking longer than originally expected.

from Reuters: Money News https://reut.rs/2L38Opw